Back to News
Market Impact: 0.6

The Pentagon Buys L3Harris Stock. Should You?

LHXNDAQNFLXNVDA
M&A & RestructuringIPOs & SPACsInfrastructure & DefensePrivate Markets & VentureCompany FundamentalsManagement & GovernanceGeopolitics & WarAnalyst Insights
The Pentagon Buys L3Harris Stock. Should You?

L3Harris is executing a major restructuring that will split its Aerojet Rocketdyne-derived propulsion assets into separate companies: AE Industrial Partners will acquire a 65% stake in Rocketdyne (L3's non-military rocket engine business) while the company will accept a $1 billion preferred-stock investment from the Department of Defense to spin off and IPO its Missile Solutions unit in H2 2026 (conversion to common expected post-IPO). S&P Global Market Intelligence estimates Rocketdyne and Missile Solutions together account for roughly $9.3 billion of revenue and just over $1.1 billion of operating profit, with the remaining “rump” L3Harris retaining about $12.3 billion of revenue and $2.2 billion of operating profit; L3 will keep minority interest in Rocketdyne. The moves materially shrink L3Harris’s scope while increasing pro forma profitability and create three investable entities, a development likely to drive revaluation and strategic repositioning for investors and defense-sector allocators.

Analysis

Market structure: The carve‑ups create three investible assets: Rocketdyne (civil engines, sold 65% to AE Industrial), Missile Solutions (military motors, $1B DoD preferred converting post‑IPO in H2‑2026), and a higher‑margin rump LHX (pro forma ~$12.3B revenue, $2.2B OP; ~17.9% operating margin vs ~11.8% for the spun businesses). Winners: LHX shareholders if the market re-rates the higher margin rump and recognizes realized cash/earnings per share accretion; AE‑backed Rocketdyne and a DoD‑backed missile spinoff should attract higher private/public multiples given strategic scarcity. Losers: suppliers or subcontractors exposed to consolidation and any competitors facing DoD preemption or exclusive contracting; commercial launch customers could face single‑vendor concentration risk. Risk assessment: Tail risks include DoD governance terms that restrict commercial sales or impose pricing controls, a program cancellation (e.g., ULA VULCAN schedule slip), or export/regulatory constraints (ITAR) that reduce addressable markets; each could cut combined operating profit by >20% in 12–24 months. Immediate (days): heightened volatility around deal disclosures; short term (weeks–months): S‑1 terms, DoD conversion mechanics and minority protections; long term (years): demand for hypersonics and space launch cycles. Hidden dependencies: Rocketdyne revenue tied to ULA/NASA program schedules and third‑party launch rates; Missile Solutions depends on DoD procurement cadence and FY appropriations. Trade implications: Direct: establish a tactical 2–3% long in LHX (ticker LHX) ahead of the Q1‑2026 preferred close to capture a re‑rating; add to 5% on confirmatory S‑1/operating‑margin beat. Pair: long LHX 3% / short BA 1.5% to express defense over commercial aerospace, timeframe 6–12 months. Options: buy a Sep‑2026 25–45% OTM call spread (size 0.5–1% portfolio) to cap premium while capturing the re‑rate; consider covered calls after position increases. Sector rotation: overweight large defense primes (LHX, LMT, NOC) by +3–5% vs underweight commercial aerospace by −2–4%. Contrarian angles: Consensus may underprice the private market value for Rocketdyne (commercial launch multiples have been 12–16x EBITDA for strategic assets) and overprice the DoD exposure risk; conversely, markets may underappreciate political/regulatory risk if DoD converts to a controlling stake (>30–50%), which could deter commercial partners. Historical parallels: separation of GE Aviation or UTC’s spinoffs led to 15–35% re‑ratings when margin profiles diverged; however, those were regulated industries with different procurement dynamics. Unintended consequences: DoD equity could trigger conflicts of interest, limiting foreign sales and compressing Rocketdyne’s commercial TAM, a scenario that would favor keeping exposure small until S‑1 terms are public.